Relations between clinical aspects and MRI findings in multiple sclerosis;Mise au point parallèle entre les aspects cliniques et IRM dans la sclérose en plaques

Revue Neurologique

Volumn 157, Issue 8-9 I, 2001, Pages 884-890

  Grimaud, J ^a   Pageot, N ^b   Rovaris, M ^c  

^a HÔPITAL NEUROLOGIQUE   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CORRELATION FUNCTION; DISEASE SEVERITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; BRAIN; COMPARATIVE STUDY; DISABILITY; NEUROLOGIC EXAMINATION; PATHOLOGY; PREDICTION AND FORECASTING; SPINAL CORD;

BRAIN; DISABILITY EVALUATION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; SPINAL CORD;

EID: 0035463226     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the "invisible" lesion load
2. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis
3. Pathologic damage in MS assessed by diffusionweighted and magnetization transfer MRI
4. Correlation of multiple sclerosis functional composite score with T2 and T1 weighted lesion load (Abstract P92)
5. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis
6. Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups
7. IRM médullaire et sclérose en plaques: Intérêt du calcul d'atrophie comme marqueur d'évolutivité de la maladie
8. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis
9. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis
10. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis
11. A spinal cord MRI study of benign and secondary progressive multiple sclerosis
12. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis
13. Magnetization transfer imaging of patients with definite MS and negative conventional MRI
14. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters
15. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis
16. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: A comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences
17. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
18. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis
19. Low-dose oral methotrexate in chronic progressive multiple sclerosis: Analyses of serial MRIs
20. The correlation of multiparametric MR measures with clinical disability in multiple sclerosis. A preliminary study
21. Magnetic resonance imaging and clinical correlations in multiple sclerosis
22. The prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation
23. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: A quantitative MR spectroscopic imaging study
24. An attempt to quantify magnetic resonance imaging in multiple sclerosis: Correlation with clinical parameters
25. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis
26. Primary progressive versus relapsing remitting multiple sclerosis in Japanese patients: A combined clinical, magnetic resonance imaging and multimodality evoked potential study
27. Magnetic resonance imaging and other techniques in diagnosis of multiple sclerosis
28. Benign versus chronic progressive multiple sclerosis; magnetic resonance imaging features
29. Assessing information in T2-weighted MRI scans from secondary progressive MS patients
30. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
31. Ventricular enlargement and brain atrophy in multiple sclerosis: A serial MRI study (Abstract 122)
32. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis
33. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
34. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression
35. MR of the spinal cord in multiple sclerosis: Relation to clinical subtypes and disability
36. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms
37. Correlates of MS disability assessed in vivo using aggregates of MR quantities
38. Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis
39. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis
40. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis
41. T1 hypointense lesion load in secondary progressive multiple sclerosis: A comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation
42. Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with "black holes", disease duration and clinical disability
43. Correlation between spinal cord MRI and clinical features in patients with demyelinating disease
44. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
45. Multiple sclerosis: Magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images
46. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods
47. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis
48. Relevance of hypointense lesions on fast fluid-attenuated inversion recovery MR images as a marker of disease severity in cases of multiple sclerosis
49. Use of the multiple sclerosis functional composite to predict disability in relapsing MS
50. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing remitting MS
51. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospecive 18 months follow-up study
52. The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS
53. Sensitivity of contrast enhanced MRI in multiple sclerosis: Effects of gadolinium dose, magnetization transfer contrast and delayed imaging
54. Evidence of widespread subtle blood-brain barrier dysfunction associated with progressive MS (abstract)
55. Proton magnetic resonance spectroscopy in normal appearing white matter of multiple sclerosis patients with benign and malignant course (Abstract 204)
56. A longitudinal study of brain atrophy in relapsing multiple sclerosis
57. Magnetic resonance studies of intramuscular interferon β1a for relapsing multiple sclerosis
58. Primary and transitional progressive MS, A clinical and MRI cross-sectional study
59. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters
60. Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study (see comments)
61. MR multiparameters in multiple sclerosis: Correlation with clinical findings (Abstract P101)
62. Normal-appearing white matter in optic neuritis and multiple sclerosis: A comparative proton spectroscopy study
63. Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol
64. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
65. Correlating MR imaging and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short TR/short TE ("T1-weighted") spinecho images
66. Histopathologic correlates of hypointense lesions on TI-weighted spin-echo MRI in multiple sclerosis
67. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging. Relation to clinical characteristics in subgroups of patients with multiple sclerosis
68. Development of hypointense lesions on T1-weighted spinecho magnetic resonance images in multiple sclerosis. Relation to inflammatory activity
69. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study
70. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis